<html>
<head>PUBMED IDs for SPRED2</head>
<body bgcolor='#C5F0F2'><h1>SPRED2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16465403/'>FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells.</a> February 9  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/20453842/'>Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.</a> June 18  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22777171/'>Placenta proteome analysis from Down syndrome pregnancies for biomarker discovery.</a> December 14  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23169297/'>Evidence for downregulation of the negative regulator SPRED2 in clinical prostate cancer.</a> April 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24970815/'>The MAPK pathway as an apoptosis enhancer in melanoma.</a> May 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26254226/'>Oxidized low-density lipoprotein is a common risk factor for cardiovascular diseases and gastroenterological cancers via epigenomical regulation of microRNA-210.</a> August 11  2015<br></body></html>
